Vendors search for new options after COVID serology fails to meet early hype

by on

Despite initial enthusiasm, these assays have struggled to carve out a significant market, hampered by concerns about test performance and the lack of a clear role in clinical decision-making.

Despite initial enthusiasm, these assays have struggled to carve out a significant market, hampered by concerns about test performance and the lack of a clear role in clinical decision-making.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: